Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy.


Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 09 09 2020
revised: 27 10 2020
accepted: 29 10 2020
pubmed: 3 1 2021
medline: 25 2 2023
entrez: 2 1 2021
Statut: ppublish

Résumé

Grading is one of the best prognostic indicators of prostate cancer with Gleason grade 5 having the worst outcome. The prognostic influence of grade 5 patterns remains uncertain. A total of 646 prostate needle biopsy sets with Gleason score (GS) 9-10 prostatic adenocarcinoma were prospectively analysed. Patterns of grade 5 were correlated with radical prostatectomy (RP) adverse findings of high tumour volume (TV), extra-prostatic extension (EPE), seminal vesicle invasion (SVI) and lymph node involvement (LNI) in 472 and biochemical recurrence (BCR) in 338 patients after RP. Mean age and serum PSA were 69 years (range 37-91) and 26.1 ng/mL (range 1.4-1800), respectively. Gleason scores were 4+5=9 in 539 (83%), 5+4=9 in 94 (15%) and 5+5=10 in 13 cases (2%). Clusters/cords, single cells, sheets and comedocarcinoma were found in 86%, 69%, 26% and 18% with a pure pattern in 25% of cases. Comparing cases with and without sheets, there were no significant differences with RP high TV (p=0.8577), EPE (p=0.5372), SVI (p=0.5183) and LNI (p=0.4323). However, the presence of sheets predicted a significantly higher BCR rate (p=0.0033), while for tumours with single cells, the interval to BCR was significantly shorter (p<0.0001). Comparing cases with and without the other patterns, two other significant differences were found. Comedocarcinoma predicted high TV (p=0.0230) and single cells predicted EPE (p=0.0101). This study shows that all patterns currently used to assign a Gleason grade 5, including sheets, comedocarcinoma, single cells and clusters/cords, are associated with aggressive outcomes validating their inclusion in grade 5.

Identifiants

pubmed: 33386122
pii: S0031-3025(20)31008-4
doi: 10.1016/j.pathol.2020.10.009
pii:
doi:

Substances chimiques

Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-204

Informations de copyright

Copyright © 2020 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Auteurs

Anthony Franklin (A)

Wesley Hospital, Brisbane, Qld, Australia.

Brett Delahunt (B)

Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand; Aquesta Uropathology, Brisbane, Qld, Australia.

Lars Egevad (L)

Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.

John Yaxley (J)

Wesley Hospital, Brisbane, Qld, Australia.

Shulammite Johannsen (S)

Aquesta Uropathology, Brisbane, Qld, Australia.

Troy Gianduzzo (T)

Wesley Hospital, Brisbane, Qld, Australia.

Jonathan Ganter (J)

Wesley Hospital, Brisbane, Qld, Australia.

Carla Pecoraro (C)

Wesley Hospital, Brisbane, Qld, Australia.

Michelle Thunders (M)

Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.

Hemamali Samaratunga (H)

Aquesta Uropathology, Brisbane, Qld, Australia; University of Queensland School of Medicine, Brisbane, Qld, Australia. Electronic address: hema@aquesta.com.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH